Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0309 per EA under NDC 68001052800. Its NADAC has been published 200 times since Aug 31, 2022.
The Low Outlier badge above means this manufacturer's average price in the MECLIZINE HYDROCHLORIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001052800
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 200 times since Aug 31, 2022, and over the history we have for it it has risen 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0309 per EA |
|---|---|
| All-time high | $0.0357 (Oct 15, 2025) |
| All-time low | $0.0265 (Oct 18, 2023) |
| 52-week high | $0.0357 |
| 52-week low | $0.0277 |
| Median price | $0.0308 |
| Average price | $0.0308 |
| Largest weekly change | +17.9% (Jul 23, 2025) |
| Weeks tracked | 200 |
| Tracking since | Aug 31, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by BluePoint Laboratories, is $0.0309 per EA (NDC 68001052800), effective Jun 24, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has risen 3.8%. It has been tracked across 200 weekly CMS publications since Aug 31, 2022.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Aug 31, 2022, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0265 (Oct 18, 2023) to a high of $0.0357 (Oct 15, 2025), with a median of $0.0308 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MECLIZINE 12.5 MG TABLET, but none are currently priced below it.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 68001052800) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification